Inscriere cercetatori

Asociatia Ad Astra a cercetatorilor romani lanseaza BAZA DE DATE A CERCETATORILOR ROMANI DIN DIASPORA. Scopul acestei baze de date este aceea de a stimula colaborarea dintre cercetatorii romani de peste hotare dar si cu cercetatorii din Romania. Cercetatorii care doresc sa fie nominalizati in aceasta baza de date sunt rugati sa trimita un email la cristian.presura@gmail.com

The IL-6 promoter polymorphism is associated with disease activitz and distability in systemic sclerosis

Domenii publicaţii > Ştiinţe medicale + Tipuri publicaţii > Articol în revistã ştiinţificã

Autori: Sfrent-Cornateanu R., Mihai C., Balan S., Ionescu R., Moldoveanu E

Editorial: J.Cell.Mol. Med, 10(4), p.955-959, 2006.

Rezumat:

Systemic sclerosis (SSc) is a rare, autoimmune disease characterized by cutaneous and visceral fibrosis. Interleukin-
6 (IL-6) is involved in the pathogenesis of many immune-mediated diseases. IL-6 plays an important role in the initiation
and promotion of fibrosis. The polymorphism in the position -174 (G/C) of the promoter region of the IL-6
gene (IL-6pr) may alter the expression of the gene. Complete linkage disequilibrium was observed between the -174
and -597 alleles. The aim of this study is to investigate the possible influence of -597 (-174) IL-6pr polymorphism
on the susceptibility and/or the clinical course of SSc in Romanian population. Genotyping of -597 variant was performed
by an RFLP method on 20 SSc patients and 26 healthy subjects. Patients having the homozygous GG (-597)
genotype had higher disease activity and disability scores than heterozygous GA patients: the European Scleroderma
Study Group (EScSG) disease activity score was 5.0 ± 3.3 in homozygous GG subjects vs. 2.4 ± 3.6 in heterozygous
GA patients (p < 0.05), and the Disability Index of the Health Assessment Questionnaire (HAQ-DI) was 1.42 ± 1.04 in homozygous GG subjects vs. 0.53 ± 0.55 in heterozygous GA patients (p < 0.05). No difference was observed in the distribution of allele frequencies between SSc patients and healthy controls. Conclusions: The GG homozygosis was found to be associated with a higher degree of illness activity and disability in SSc patients. No statistically significant differences were found between SSc patients and healthy controls with respect to the -597 allele distribution.

Cuvinte cheie: interleukin-6 (IL-6) • gene polymorphism • systemic sclerosis (SSc) • fibrosis • cytokine

URL: http://www.jcmm.ro/download/jcmm010.004.08.pdf